Lung Cancer Symposium: Early Diagnosis & Screening, Benchmarking the Nordics+
Join this symposium and take part in discussions with experts as they frame the challenges of lung cancer and address clinical models for risk prediction, early diagnosis, and screening in the Nordics. A panel discussion will include implementation models for screening and selection.
Agenda
09:30-10:00
REGISTRATION & COFFEE
10:00–10:15
Welcome & Introduction
Charlotte Homme, Head of Membership & Events, Oslo Cancer Cluster
Ole Alexander Opdalshei, Deputy Secretary General, Norwegian Cancer Society (Assisterende Generalsekretær, Kreftforeningen)
10:15–10:30
The challenges of early detection and screening of lung cancer
Oluf Dimitri Røe, MD, PhD, Professor, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science & Technology (NTNU), Department of Oncology, Levanger Hospital, Levanger, Norway, Lung Cancer Symposium, Co-chair & Moderator
10:30–10:50
A WHO perspective, IARC, Lyon
Dr. Mattias Johansson, Head Scientist, International Agency for Research on Cancer (IARC/WHO) Lyon, France (Digital presentation)
10:50–11:10
Finland – A perspective on early diagnosis and screening
Aija Knuuttila, MD PhD, Associate Professor, Department of Medicine, HUS Comprehensive Cancer Center, Helsinki, Finland
11:10–11:30
Coffee break and networking session
11:30-11:50
Iceland – A perspective on early diagnosis and screening
Hrönn Harðardóttir, Pulmonologist, Landspítali University Hospital, Reykjevik, Iceland
11:50–12:30
Sweden – A perspective on early diagnosis and screening
Dr. Bengt Bergman, M.D, Ph,D,, Respiratory Medicine, Sahlgrenska University Hospital, Göteborg
12:30 – 13:30
An invitation to lunch
13:30-14:00
Denmark – A perspective on early diagnosis and screening
Zaigham Saghir, MD, PhD, Professor, Department of Respiratory Medicine, Gentofte University Hospital, Hellerup, Denmark
14:00-14:20
Norway – Screening without losing, the HUNT Lung Cancer Model for selecting those at high risk
Oluf Dimitri Røe, Prof. MD PhD
Norway – TIDL Study, First Nordic Pilot Screening Program
Haseem Ashraf, Associate Professor, University of Oslo, Oslo, Norway, Department of Imaging, Akershus University Hospital, Oslo, Norway haseem.ashraf@gmail.com
14:20-15:00
Panel discussion scientists and stakeholders
Moderated by Oluf Dimitri Røe, NTNU and includes all speakers on-site & Ole Alexander Opdalshei, Deputy of Research, Norwegian Cancer Society
15:00-15:15
Summary
Note: All speakers will be in-person except where noted as “presenting digitally”.
The symposium is:
Organized by: Oslo Cancer Cluster & Norwegian University of Science & Technology (NTNU)
Sponsored: Astra Zeneca & Daiichi Sankyo (Members of Oslo Cancer Cluster)
Supported by: Innovation Norway (Mature Clusters)
Contact Details (Chairs):
Oluf Dimitri Røe, MD&PhD, Professor, Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), email: oluf.roe@ntnu.no
Charlotte Wu Homme, Head of Membership & Events, Oslo Cancer Cluster, email: cwh@oslocancercluster.no
Transportation: Montebello Bus Stop, Montebello “T-ban Stop”, adjacent to Radium Hospital
Sponsors
